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Abstract 
 
 Nanoparticles are particles with at least one dimension between 1 and 100 nm. Due to their 
unique properties, gold nanoparticles (AuNPs) are used for drug delivery, diagnostics and cellular 
imaging, but there are concerns they interfere with neuronal development. In this study, we tested for 
potential neurotoxic effects by analyzing behavioral changes in zebrafish (Danio rerio) embryos and 
larvae exposed to AuNPs. 
We injected three different sizes of AuNPs (20, 40 and 80 nm) into either embryos at 2-4 hours 
post fertilization (hpf), or larvae, at 72 hpf. The AuNPs were delivered into the yolk sack of the embryos 
and the duct of Cuvier (i.e. the blood stream) in the larvae. Five concentrations of each AuNPs were 
tested in triplicate (1000, 500, 100, 50 and 5 µg/ml), all of which were below the lethal dose. 
Behavioral changes are a good indicator of neurotoxicity. Therefore, we used an automatic 
tracking system to analyze the distance travelled and time spent active in 96 hpf zebrafish. These 
endpoints were tested under a light-dark-light photo regime. In addition, we monitored motorneuron 
development using whole-mount immunohistochemistry staining for anti-acetylated tubulin (α-AT) at 48 
hpf. 
We found that embryos injected with all three AuNP sizes showed reduced locomotor activity 
during the dark phase compared to controls, but there was no AuNP effect in the light phase. These 
reductions were concentration dependent only in 80 nm AuNPs, whereby the highest doses resulted in 
the lowest movement. We did not find any significant interaction of AuNP size on the reduction in 
locomotor activity. In contrast, we found no clear response patterns in larvae injected with AuNPs at 
72hpf. Here, some concentrations increased, whereas others decreased, activity levels compared to 
controls during the dark phase. With respect to motorneuron development, we found larvae exposed to 
all sizes of AuNPs had shorter axons than controls.  
These results demonstrate that AuNPs have an effect on zebrafish behavior and axon 
development. As the behavioral effects were more apparent and consistent following the earlier 
exposure window, i.e. embryos, this suggests AuNPs interfere with the early stages of neurological 
development.   
Keywords: Gold nanoparticles, zebrafish, locomotor behavior, motorneurons. 
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Introduction 
 
Nanoparticles are defined as particles with at least one dimension under 100 nm. Due to their 
small size, these particles have unique mechanical, electrical and optical properties with multiple 
potential applications (Donaldson et al. 2004, Lines 2008).  As such, nanotechnology is a growing 
commercial industry with an economical importance that is predicted today to be 3 trillion dollars (Lux 
Research Inc. Report, 2009). Currently commercial applications of nanoparticles are highly diverse, 
including their use in the textile industry, electronics, plastics, cosmetics, water treatment and the 
disinfection of medical devices  (Lines 2008).  
Nanoparticles have many biomedical applications, including maintaining circulating drug 
concentrations within the blood or helping to target specific cells or organs (Moghimi et al. 2001, 
Panyam and Labhasetwar 2012). Due to their smaller size, nanoparticles can travel through the 
organism more efficiency than larger particles, increasing access to target organs (Kreyling et al. 2002). 
At the cellular level, nanoparticles may enter cells via different pathways. However, whether 
nanoparticles are taken up via active recognition or by passive processes remains unclear (Unfried et al. 
2007). Nevertheless, the physicochemical properties of nanoparticles, such as size, shape, 
agglomeration or chemical composition, and characteristics of the target cells are known to effect the 
uptake pathway (Unfried et al. 2007).  
Gold nanoparticles (AuNPs) are of particular interest within the field of biomedicine, due to their 
unique optical and electrical properties (Giljohann et al. 2010). Applications in biology and medicine of 
AuNPs include cell uptake (Penn et al. 2003, Connor et al. 2005, Chithrani et al. 2006, Chithrani and Chan 
2007), drug delivery (Bowman et al. 2008), gene transfection (Sandhu et al. 2002, Ghosh et al. 2008), 
cancer cell detection (Medley et al. 2008), antiviral activity (Bowman et al. 2008) or imaging (Faulk and 
Taylor 1971, Loo et al. 2005, Javier et al. 2008) amongst others. The use of AuNPs in biomedicine has 
exponentially increased over recent years and new medical and pharmaceutical applications are being 
proposed frequently. For instance, AuNPs are used in plasmodic photothermal therapy. This therapy is 
based on the characteristic that AuNPs have an absorption maximum in the visible or near-infrared 
region and become very hot when irradiated with certain light frequencies. By apply specific coatings, 
AuNPs can be transported into target cells. Once within, the target cells can be irradiated and as a 
consequence of the local heating of AuNPs, these cells die (Dykman and Khlebtsov 2012). This therapy 
has a great potential use for cancer treatment. AuNPs have also been used as vectors to deliver the pro-
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inflammatory cytokine, tumor necrosis factor (TNF), to solid tumors in rats. When AuNPs conjugated 
with TNF were injected intravenously into rats, they rapidly accumulated in tumor cells but not in 
healthy cells (Paciotti et al. 2004). Once within the tumor cells, TNF instigates an inflammatory response, 
destroying the tumor. Besides antitumor substances, AuNPs can also be used to deliver antibiotics or 
other antibacterial agents. As an example, Gu and collaborators (2003) used AuNPs conjugated with the 
antibiotic vancomycin that shows effects against several enteropathogenic strains of Escherichia coli, 
Enterococcus faecium, and Enterococcus faecalis, including resistant strains. Another promising use of 
AuNPs is as therapeutic vaccines. Here, Wang and collaborators (2011) successfully conjugated a protein 
vaccine with AuNPs of 15 nm with positive results in rats. AuNPs as an adjuvant stimulated a stronger 
immune response without producing detectable toxicity and physiological damage than the vaccine 
alone. 
  Although AuNPs are consider highly biocompatible compared to other nanoparticles (Bar-Ilan et 
al. 2009), their toxic potential is still largely unknown (Alkilany and Murphy 2010). Due to the small size 
of nanoparticles, the surface area per volume ratio is much greater than bulk compounds, and therefore 
chemically more reactive and biologically more active per given mass (Donaldson et al. 2004, Kreyling et 
al. 2006). There are many studies showing that nanoparticles may cause greater damage than their 
respective larger sized particles at the same concentration. For instance, Zhang and collaborators (2003) 
conducted an experiment where rats were exposed to different concentrations of either nickel 
nanoparticles (20 nm) or standard nickel (5 µm). Nickel nanoparticles produced a more severe 
inflammatory response in the lungs than the same concentrations of standard nickel. In a different study 
with mice, intratracheal administrated of 20 nm titanium dioxide nanoparticles was found to induce a 
much greater inflammatory response than larger nanoparticles, 250 nm, at the same mass dose 
(Oberdörster et al. 2005). Furthermore, nanoparticles can form agglomerations when come in contact 
with biological media resulting in a change in their surface area, charge and size from the original 
nanoparticle (Wick et al. 2007, Kettiger et al. 2013). These parameters may also affect the toxicity 
outcomes (Truong et al. 2012). Nanoparticles may also be coated or be given surface modifications that 
can affect their uptake and behavior within tissues, and therefore their toxicity. For example,  El Badawy 
and collaborators (2010) showed with four different coated silver nanoparticles (uncoated, citrate 
coated, polyvinylpyrrolidon coated and branched polyethyleneimine coated) that toxicity on gram 
positive bacteria was dependent on the surface charge rather than their shape or size. Together, these 
studies demonstrate that particle size, coating composition and aggregation, are critical to understand 
cell uptake mechanism and kinetics, which is of great importance to understand toxicity. As such, it is 
 3 
  
vital that more research is conducted on the different aspects of nanoparticle toxicity, especially as in 
Europe the use of chemicals is regulated by REACH (Registration, Evaluation, Authorization and 
Restriction of Chemicals), but the safety documentation is typically only related to the bulk compounds 
with no correction for particle size or coating (EU Commission, 2012).  
Knowledge on the absorption and distribution of AuNPs is very important to understand the 
possible target organs of these particles. Physicochemical characteristics such as size and surface 
chemistry composition may critically affect the uptake and distribution behavior of AuNPs. For instance, 
studies in mice show that after oral administration uncoated AuNPs were taken up in the small intestine 
by trespassing through gaps created by extruding enterocytes. This process was found to be size 
dependent whereby smaller particles were absorbed faster (Hillyer and Albrecht 2001).  De Jong and 
collaborators (2008) show in a study with rats that size determined the distribution of AuNPs when 
exposed intravenously. In this study, the smallest particles, 10 nm, were found in all the organs that they 
studied, the liver, spleen, lungs, kidneys, testis, thymus, heart and brain, and the concentration was 
highest in the liver. In contrast, larger particles of 50, 100 and 250 nm were found mostly in the liver and 
spleen. Along the same line of study, Zhang and collaborators (2011) found that AuNPs coated with 
polyethylene glycol (PEG) were distributed differently in the organs depending on the particle size. 
AuNPs of 5 and 10 nm mainly accumulated in the liver of mice, particles of 30 nm preferentially 
accumulated in the spleen, whereas particles of 60 nm had a wider distribution with highest 
accumulation in liver and kidney.  
The physicochemical properties of AuNPs also effect cell uptake (Alkilany and Murphy 2010), an 
understanding of which is important to assess both biomedical possibilities and hazardous outcomes 
(Chithrani et al. 2006, Rosi et al. 2006, Han et al. 2007). The majority of studies propose AuNPs to be 
internalize within cells by receptor mediated endocytosis (RME), which is very dependent on particle 
size (Chithrani and Chan 2007). In a study with mammalian cells and AuNPs, 50 nm was found to be the 
optimal uptake size (Chithrani et al. 2006), these particles being taken up faster than smaller sizes (14 
nm) and bigger (74 nm) particles. In addition to the RME uptake mechanism, AuNPs may also enter cells 
by direct penetration. For instance, Verma and collaborators (2008) showed that anionic and 
hydrophobic coated AuNPs of 5 nm may enter the cells directly without perturbation of the cell 
membrane in an action similar to cell-penetrating peptides, but this uptake mechanism is less common 
than RME. 
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Though many studies suggest that AuNPs are nontoxic, others report the opposite (Alkilany and 
Murphy 2010). For instance, several studies have found that AuNPs may induce cellular toxicity through 
different mechanisms such as oxidative stress, the disruption of cell membranes, inflammation, and DNA 
damage (Unfried et al. 2007, Aillon et al. 2009, Pan et al. 2009). Similar to other types of nanoparticles, 
size is an important characteristic in AuNP toxicity. For instance, 1,4 nm AuNPs produced necrosis, 
mitochondrial damage and induced oxidative stress in a number of cell lines , whereas 15 nm AuNPs 
with the same coating showed no hazardous effect (Pan et al. 2007). A second example is that of the 
study by Zhang et al. (2011), which demonstrated that PEG-coated AuNPs of 10 and 60 nm induced 
greater liver toxicity in mice, based on the levels of alanine transaminase and aspartate transaminase, 
compared to 5 and 30 nm AuNPs. The physicochemical properties of AuNPs may also influence their 
hazardous properties. For instance, the coating chemistry of AuNPs may be responsible for the toxic 
effects. Here, an in vitro study with cationic AuNPs of 2 nm showed that these particles were toxic at a 
certain dose whereas the same particles, but negatively charged, were non-toxic (Goodman et al. 2004).  
Studies in vivo also support that toxic potential depends on the physicochemical characteristics of 
AuNPs. For instance, Truong et al. (2012) evaluated the toxic effects of AuNPs coated with three 
different functional groups (positively charged, negatively charged and neutral) using zebrafish (Danio 
rerio). They found that AuNPs functionalized with positively or negatively charged coatings induced toxic 
effects, whereas AuNPs functionalized with a neutral coating did not exhibit any effect, proving that 
coating chemistry plays an important role in AuNP toxicity. Together, these studies confirm that size and 
coating chemistry of AuNPs are critical factors to understand AuNP toxicity, but other particle 
characteristics such as aggregation or particles shape, may also play an important role in toxicity (Hillyer 
and Albrecht 2001, Giljohann et al. 2010).  
In the recent years, the toxic effects of AuNPs on the central nervous system (CNS) have been 
studied (Oberdörster et al. 2009, Truong et al. 2012, Kim et al. 2013). Due to the small size, 
nanoparticles have been suggested to be able to cross the blood brain barrier (BBB) (Oberdörster et al. 
2004). Although translocation across the tight junctions of the human BBB has not been conclusively 
demonstrated, studies with rats show that AuNPs coated with rat serum albumin were able to enter to 
the olfactory bulb when exposed intranasally (Oberdörster et al. 2009). In a more recent experiment 
with zebrafish embryos exposed to AuNPs, the researchers show significant differences on the 
swimming behavior, a proxy for neurotoxicity, of AuNP exposed zebrafish (Kim et al. 2013). They also 
found these effects were persistent into adulthood and suggested that changes on behavior were linked 
to damage in the CNS (Truong et al. 2012). Moreover, a different study from the same group show that 
 5 
  
AuNPs of 1,3 nm coated with the cationic ligand N,N,N-trimethylammoniumethanethiol (TMAT), 
produces changes in the locomotor behavior of zebrafish embryos. In this study, they also reported 
abnormal axon development in AuNP exposed fish, providing a link between behavioral changes and 
neurotoxic effects (Kim et al. 2013). 
Traditional in vivo models to study toxicity include mice and rats, but more recently, there has 
been an increase in the use of zebrafish. The zebrafish is a tropical freshwater fish of the cyprinid family 
that is a well-established model organism in biological research (Aleström et al. 2006, Lieschke and 
Currie 2007), including neurogenesis (Legradi et al. 2014). Due to this knowledge base, it has now 
become a popular model in developmental toxicity, including neurotoxicity. As zebrafish have a close 
homology with the human genome, as well as physiological and anatomical similarities including 
endothelial cells, presence of blood brain barrier and immunogenic responses, this model can be used to 
predict toxicity effects in humans (Zhang et al. 2003, Hill et al. 2005, Aleström et al. 2006). In addition, 
zebrafish and mammals show similar physiological responses to toxic substances, such as induction of 
metabolizing enzymes and oxidative stress (Rubinstein 2003). 
The zebrafish model presents many advantages over other animal models. Small size, 
robustness, reproductive capacity and short generation time makes this model easy to maintain under 
experimental conditions and inexpensive compared to other traditional animal models such as mice 
(Westerfield 2000). Zebrafish reach sexual maturity three months after fertilization and can produce up 
to 200-300 eggs per spawning (Westerfield 2000). The embryos are transparent, develop ex utero, the 
developmental stages are well described (Kimmel et al. 1995), and the larvae hatch during the first 2-3 
days (Westerfield 2000). Embryos and early larvae are transparent, which allows for the study of 
organogenesis in real time, and their development can be monitored under the microscope (Kimmel et 
al. 1995).  
Zebrafish larvae prior to 5 days post fertilization (dpf) are defined by the current European 
animal directive (2010/63/EU) as nonanimals, therefor studies performed before 5 dpf are considered 
an in vitro model and an alternative to conventional animal testing. In 2013, the fish embryo acute 
toxicity (FET) test was approved and published as the OECD test guideline number 236 (OECD 2013). This 
test guideline intends to determinate the acute toxicity of chemicals using zebrafish embryos up to 96 
hours post fertilization (hpf). The FET test was designed as an alternative to the fish acute toxicity test, 
e.g. OECD test guideline number 203 (OECD 1992), following the recommendations of REACH to 
promote the development of alternative methods according to the 3Rs principle, replacement, 
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reduction and refinement (Russell et al. 1959). The use of zebrafish embryos is considered as a 
replacement or refined method. Moreover, the FET test has been shown to be a good alternative to the 
fish acute toxicity test in hazard identification and risk assessment studies (Lammer et al. 2009), 
although it presents some limitations, such as the inability to perform dietary exposures. The FET test is 
conducted with zebrafish embryos up to 96 hpf, and the exposures are recommended to begin within 1 
hpf (Lammer et al. 2009, Braunbeck et al. 2014), but zebrafish larvae do not fed until after 5 dpf 
(Westerfield 2000).  
Parallel to the FET test, zebrafish embryos have been used for studying neurotoxicity and 
developmental neurotoxic effects of chemicals (Baraban et al. 2005, Irons et al. 2010, Selderslaghs et al. 
2010, Cowden et al. 2012, de Esch et al. 2012). The neurological system of zebrafish and its 
development stages are well characterized. Neurogenesis starts at 6 hours post fertilization (hpf) when 
the first cells that will form the nervous system appear. As soon as 24 hpf, the different parts of the 
brain are formed and the first neurons are connected by axons. Organized escape movements are 
displayed at 27 hpf. The brain is fully formed at 48 hpf and at 96 hpf, the nervous system is nearly full 
developed (Kimmel et al. 1990, Blader and Strähle 2000, de Esch et al. 2012, Legradi et al. 2014). In 
addition, zebrafish develop a blood-brain barrier similar to humans. The maturation of this structure 
starts developing at 3 dpf and is fully developed at 10 dpf (Fleming et al. 2013). This knowledge on the 
different stages of development in the zebrafish nervous system opens up great opportunities for the 
study of different endpoints in developing neurotoxicity.  
In neurotoxicity testing, the effect of neurotoxic substances may be different depending on the 
time of exposure. The developing nervous system is more vulnerable to chemicals than the adult 
nervous system, therefore, special attention should be given to developmental neurotoxicity (Grandjean 
and Landrigan 2006). Adult and developmental neurotoxicity assessments are normally studied using 
behavioral in vivo tests. Technologies such as video tracking systems have become very popular to study 
behavioral effects. From these tests, the light/dark transition test is one of the most popular for 
zebrafish because it allows studying different behavioral endpoints. The test consists of tracking 
zebrafish larvae swimming behavior through light and dark conditions. To monitor the behavior during 
the dark phase, an infrared light is placed under the multi-well plate. From this test, behavioral 
endpoints such as distance, speed, time active and areas of movement can be monitored (Legradi et al. 
2014), endpoints which are similar to the commonly used open field test in mammals. The endpoints 
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measured using the light/dark transition test can be related to anxiety (Burgess and Granato 2007) as 
well as other neurological (Baxendale et al. 2012) and neuromuscular disorders (Chen et al. 2012). 
Due to the concerns about their potential as developmental neurotoxins, our main objective 
was to investigate the effects of AuNPs on zebrafish behavior. A second objective was to determine 
whether particle size would affect toxicity, as previous research has found particle uptake is more 
efficient at sizes of around 40 nm compared to larger and smaller particles. Finally, as AuNPs have 
previously been found in heart tissue of zebrafish following exposure, our third objective was to test 
whether AuNPs affect heart function. Our hypothesis were as follows, i) AuNP exposure will disrupt 
normal CNS development leading to alterations in behavior, ii) 40nm AuNPs will induce greater effects 
on behavior and axon morphology than smaller and larger particles of 20 and 80 nm, respectively, and 
iii) AuNP exposure will alter cardiac function. To test these hypothesis we measured two behavioral 
endpoints, the distance moved and the time spent active during a light-dark-light photo regime, in 
zebrafish exposed to one of 20, 40, or 80 nm AuNPs either prior to, or towards the later stages of, 
neurogenesis. In addition, we measured primary motor neuron axon length in larvae as an indicator of 
CNS development after initial exposure to one of three sizes of AuNPs prior to neurogenesis. Finally, we 
measured the heart rate in zebrafish larvae initially exposed to one of three sizes of AuNPs prior to heart 
development.       
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Material and Methods 
 
Gold nanoparticles 
 
Gold nanoparticles (AuNPs) were provided by the Luxemburg Institute of Science and 
Technology (LIST). These AuNPs are a commercial product distributed by NanoComposix (Prague, Czech 
Republic). Three different sizes, 20, 40 and 80 nm, of the product line NanoXact gold nanospheres 
(NanoComposix) were used. These nanoparticles were provided as aqueous solutions, diluted in 
distillated water and coated with citrate. 
Each of the three AuNPs was maintained in stock solutions at 1000 µg/mL. Table 1 describes the 
chemical composition of each stock solution. The stock solutions were serially diluted to achieve 
concentrations of 500, 100, 50 and 5 µg/mL by adding distillated water. Pilot studies indicated that the 
highest dose used, 1000 µg/ml, was within the non-lethal range. Following the producers instructions, 
AuNPs were stored in the dark at 4⁰C throughout to avoid aggregation of the particles. 
 
Table 1. Components of the stock solution (NanoComposix MSDS). The solution was supplied in a concentration of 1 
mg/ml. 
Ingredients % by Mass 
Gold (as colloid) 0.005 
Sodium Citrate Dihydrate 5.8x10-5 
Water >99 
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Characterization 
 
The characterization of each of the three AuNPs stock solutions was conducted by two methods, 
Transmission Electron Microscopy (TEM) and Nanoparticle Tracking Analysis (NTA). TEM analysis was 
conducted at the University of Oslo (Faculty of Mathematics and Natural Sciences, Department of 
Biosciences). Here, 2 µL of each of the three AuNP stock solutions were applied to a copper mesh coated 
with formvar and the samples were carefully dried with filter paper, paying special attention not to 
touch the surface of the mesh to avoid sample contamination. The grid was then air-dried for 10-15 
minutes before imaging. Samples were then analyzed using a Philips CM100 Transmission Electron 
Microscope, with an Olympus Quemesa camera and Olympus software. Several pictures of each AuNP 
sample were taken (Figure 1) from which 30 random particles were measured using the imaging 
software ImageJ (Rasband 2014).  
In addition to TEM analyses, our partners in Luxembourg ran a NTA test on the stock solutions of 
each of the AuNP sizes. This method identifies each individual particle and tracks its Brownian motion, 
from which the diffusion coefficient is obtained and then used to calculate the hydrodynamic diameter. 
The test was conducted in triplicate for each AuNP size. NTA measures nanoparticle size distribution and 
concentration to complement the data from TEM analysis (Figure 2). 
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Figure 1. AuNPs pictures from Transmission Electron Microscopy (TEM) imaging. A) 20 nm AuNPs; B) 40 nm AuNPs; 
C) 80 nm AuNPs; D) Boxplots of size distribution of all three sizes of AuNPs. The boxes represent the 50% of the data 
including values between the first and third quartile. The whiskers represent the lowest and highest values and the 
dots are outliers (over 1,5 times the value of the third quartile). All sizes groups are significant different to each 
other (GLM, p<0,001). 
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D AuNPs 20 nm AuNPs 40 nm AuNPs 80 nm 
Size distribution Mean: 31 ± 2 nm 
Mode: 24 ± 1,2 nm 
Mean: 50 ± 3,2 nm 
Mode: 40 ± 1,2 nm 
Mean: 83 ± 5,5 nm 
Mode: 71 ± 2,6 nm 
Particle concentration 4,22 ± 0,37*108 
particles/ml 
2,85 ± 0,04*108 
particles/ml 
1,70 ± 0,10*108 
particles/ml 
Completed tracks 4870 2722 1523 
 
Figure 2. Size distribution curve from particle characterization using Nanoparticle Tracking Analysis (NTA). The 
narrow shape of the curve means that no nanoparticles agglomerations are found in the stock solution. Each test 
was done in triplicate. Size distribution of A) 20 nm AuNPs; B) 40 nm AuNPs; C) 80 nm AuNPs, and D) table with 
results from NTA test. Mean size of all the nanoparticles analyzed. Mode represents the most repeated size of all 
AuNPs tested. 
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Zebrafish 
 
Zebrafish were housed at the Model Fish Unit (MFU), department of experimental biomedicine 
at the Norwegian University of Life Sciences (NMBU), Faculty of Veterinary Medicine and Biosciences. A 
new population of AB wild-type zebrafish was reared for this project. Fertilized embryos (19/12/2013) 
were kept in petri dishes with autoclaved system water and methylene blue to avoid fungal infection. At 
24 hpf, embryos were bleached to avoid bacterial infection and they were kept in an incubator for six 
days at 28 ⁰C where water was changed daily. Zebrafish larvae begin to feed at approximately 6 (dpf), 
embryos were transported to 1 L static beakers on a bench with controlled temperature (28 ± 2 ⁰C) 
where water was changed daily. Here, larvae were fed four times every day (Table 2) with live feed, 
artemia and rotifers, or dry feed from Special Diet Services (SDS) (Essex, UK). At 21 dpf, zebrafish larvae 
were transferred to tanks in a flow through aquarium system. Water conditions were monitored weekly 
(see Table 3 for specifications) and the fish were kept on a light:dark regime of 14:10. Following 
standard procedure within the facility, fish were fed three times daily (Table 2) with a shift on to the dry 
feed composition as fish grew. Once the fish became adults around four months after fertilization, they 
were separated into male and female tanks. After six months, fish were mature and capable of 
producing fertilized embryos. 
 
Table 2. Feeding routines at Model Fish Unit. Artemia and rotifers are live feed; SDS is dry feed from Special Diet 
Services.  
 Morning 09:00 Noon 12:00 Afternoon 15:00 
Larvae (<21 dfp) Artemia SDS100 (+ Rotifers) Artemia 
Juvenile (60-100 dfp) Artemia SDS 200 - 300 Artemia 
Adult fish (>100 dfp) Artemia SDS 400 Artemia 
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Adult fish populations contained approximately 75 females and 90 males were divided in to 
three populations (n=6 tanks, n=3/sex) to avoid breeding overuse. When fertilized embryos were 
required, fish from one of the three populations (females and males) were transferred into 1 L breeding 
tanks divided by a transparent barrier that separated females and males. In the females’ side, marbles 
were added to mimic natural conditions, i.e. females lay their eggs in stony environments. The fish used 
for breeding were denied the last feed of the day and left in the breeding tanks overnight. In the 
morning, when the lights in the aquarium went on, the barrier was removed and the fish began 
breeding. Approximately one hour after removing the barrier, the fish were transferred back to their 
home tanks and the fertilized embryos were collected. 
 
Table 3. Physicochemical data of the system water of the Model Fish Unit. Values tested and controlled weekly. 
 Normal range Healthy range 
pH 7.5-7.6 7.0-8.0 
NO2 <0.1 mg/L <0.1 mg/L 
NO3 <25 mg/L <50 mg/L 
NH3 <0,05 mg /L <0.1 mg/L 
Temperature 28± 1ºC 26-30ºC 
Conductivity (µs/cm) 500 400-600 
 
 
Behavioral Analyses 
 
For behavioral analyses, two time points of exposure were selected. The first at the embryonic 
stage, 2-4 hpf, to test potential developmental effects and second at the larval stage, 72 hpf, to test for 
the systemic effects of nanoparticles.  
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Zebrafish were exposed to AuNPs via microinjection (Figure 3). This method allowed for the 
introduction of the AuNPs directly into a precise area of the zebrafish embryo or larvae. Microinjections 
were conducted using the nitrogen pressurized microinjector Picospritzer III (Parker Hannifin Corp, 
Cleaveland, OH, USA) using an ultrafine needle (Clarck Electromedical Instruments, Pangbourne, UK. 
Outer diameter 1 mm; inner diameter 0,78 mm). 
 
 
Figure 3. Pictures of microinjections of AuNPs. A) Microinjection at 2 hpf embryo in the yolk sac. B) Microinjection 
at 72 hpf larvae in the duct of Cuvier. In this image, phenol red is being injected into the blood circulation and the 
dye can be seen passing over the yolk sac. 
 
For embryonic exposure, fertilized zebrafish embryos were collected in the morning and placed 
in petri dishes. In advance, microinjection needles and 1% agarose filled petri dishes (VWR, Letterworth, 
UK) were prepared. Embryos at 2 hpf were then placed on the agarose plates along the edge of a glass 
slide. The glass slide acted as a barrier to keep the embryos in position during injection. Using the 
microinjector, 30 embryos were injected with 1 nL of each of the three sizes, 20, 40 and 80 nm, of 
AuNPs at each of five concentrations, 1000, 500, 100, 50 and 5 µg/mL, directly into the yolk sac of the 
embryos.  In addition, we had two controls. To control for the carrier media, 30 embryos were injected 
with 1 nL of distilled water. To control for microinjection, 30 embryos were left untreated.  
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At approximately at 6 hpf, 20 viable embryos of each AuNP size and concentration were 
selected and transferred into two 96 well plates (70 embryos per plate) (Figure 4) and filled up with 300 
µL of egg water. These plates were then placed in an incubator at 28⁰C until the time of analyses. Every 
day, 50% of the embryo media was exchanged with fresh media and mortality was recorded. Depending 
on the facility availability, one or all sizes of nanoparticles were injected in one session. 
 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A Distillated water 
Empty 
wells 
B 1000 µg/ml 
C 500 µg/ml 
D 100 µg/ml 
E 50 µg/ml 
F 5 µg/ml 
G Untreated embryos 
H Empty wells 
Figure 4. Schematic representation of well plates used in the experimental design. Seventy larvae were placed in 
each 96 well plate.  
 
For larval exposure, fertilized zebrafish embryos were collected, placed in petri dishes and kept 
in an incubator at 28⁰C until 72 hpf. Dead embryos were cleaned out daily and all viable embryos were 
transferred to a new petri dish with clean egg water every day. At 72 hpf, larvae were selected for 
microinjection of AuNPs. Larvae were first anesthetized with 3 mL of 4% tricaine (PharmaQ, Oslo, 
Norway) diluted in 50 mL of egg water. Thereafter 20 larvae were injected with each of the three sizes of 
AuNPs, 20, 40 and 80 nm, at each of five concentrations, 1000, 500, 100, 50 and 5 µg/mL. The AuNPs 
were delivered directly into the systemic circulation via the duct of Cuvier, a structure between the yolk 
sac and notochord, where there is a widening of the blood vessels (Figure 5). In pilot studies, 
microinjections in different areas of the larvae were tested, including caudal vein, heart and yolk sac. 
The duct of Cuvier was chosen because the area is more accessible and the damage to the larvae was 
minimum. After the injections, all larvae were transferred into 96 well plates (Figure 4) and placed in an 
incubator at 28⁰C until the behavioral assay was conducted. In addition, mortality was recorded prior to 
the analysis. 
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For behavioral analyses, each experiment was undertaken in triplicate at both exposure time 
points, embryonic and larvae, to gain statistical power. Overall, the behavior of 2256 larvae were 
analyzed (Table 4). 
The current European animal directive (2010/63/EU) defines larvae under 5 dpf as nonanimals. 
Therefore, after the behavioral test, all larvae were euthanized before they reach 120 hpf with 
Benzocaine (ACD Pharmaceuticals, Leknes, Norway). 
 
 
Figure 5. Picture of the anterior part of a zebrafish larvae at 72 hpf. Main blood vessel structures targeted for 
microinjection represented in red. 
 
To measure axon length, 30 embryos were injected into the yolk sac with all three sizes of 
AuNPs at three concentrations, 1000, 100, and 5 µg/mL, and a distillated water control was included. 
The embryos were injected at 2-4 hpf and transferred to petri dishes, where water was changed daily 
until 48 hpf when larvae were dechorionated and euthanized with tricaine. These larvae were 
transferred into Eppendorf tubes and fixed with formaldehyde 4% (VWR, Netherlands), then stored 
overnight at 4⁰C. As long-term exposure to formaldehyde will damage the epitopes of the target 
proteins, samples were first dehydrated by serial washes in increasing concentrations of methanol 
(Sigma Aldrich, St Louis, MO, USA. Serial dilutions included 30, 50, 70% methanol in PBS) before finally 
being stored in 100% methanol at -20⁰C. 
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Table 4. Number of larvae analyzed in the behavioral test at each AuNPs size and concentration.  
 Embryo exposure Larvae exposure 
 AuNP20 AuNP40 AuNP80 AuNP20 AuNP40 AuNP80 
Untreated 58 52 58 51 59 52 
Distillated water 55 50 57 51 54 54 
5 µg/mL 55 51 54 57 50 56 
50 µg/mL 54 50 56 59 53 57 
100 µg/mL 55 52 49 60 59 57 
500 µg/mL 51 52 45 56 56 54 
1 mg/mL 48 53 39 58 54 55 
 
 
Heart Rate  
 
Due to the transparency of the zebra fish larvae, the heartbeat can be counted with the aid of a 
light microscope. Larvae used in the behavioral assay were observed at 48 hpf at 63X magnification 
within the wells in which they were housed, and heart beats were counted visually for 15 seconds. 
These data were extrapolated to beats per minute. 
 
Behavioral Tests 
 
Behavioral assays were conducted using an automated behavior recording system, the Zebrabox 
(View Point, Lyon, France), and the custom software provided. The Zebrabox consists of a video camera 
placed above a chamber that can house a multi-well plate. In the chamber, light and dark regimes are 
under direct control and fish may be exposed to different stimuli such as light flashes or vibration using 
the software included in the system.   
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For this experiment, locomotor behavior endpoints, including distance covered and the time 
spent active, of zebrafish larvae were measured when exposed to different light conditions. Each 96 well 
plate with zebrafish larvae (approximately 100 hpf) were recorded for a period of 40 minutes that 
included 10 minutes of acclimation in light followed by 10 min of light, 10 minutes of dark (infrared light) 
and 10 minutes of light again. The first 10 minutes used for acclimation were not included in the 
analysis. Distance covered and time of activity of each zebrafish larvae were recorded through the light-
dark-light conditions with the software included in the Zebrabox (Figure 6). Prior to starting the test, the 
room was heated up to 28⁰C and maintained at this temperature during the test. The software works by 
monitoring alterations in pixel color. A larvae is identified by its contrast in color with that of the 
background. To prevent false positives for larval detection, the threshold value can be adjusted. By 
increasing the value, only the strongest contrasting pixels are recognized as the larvae. As such, the 
software typically follows the eyes, which are the most pigmented tissue of the larvae. This setting was 
optimized prior to testing, based on comparing live images with the ability of the software to detect the 
larvae, and set at a threshold value of 20 throughout. In addition, to avoid false positives for active 
swimming it is possible to set a minimum movement detection threshold. This was set to a minimum 
speed detection of 3mm/sec.  
 
 
Figure 6. Outcome of the analysis from the Zebrabox tracking system. Each circle represents the movement of one 
larvae inside a well. Green lines represent slow movement of the larvae and red lines represent fast movement. 
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Immunohistochemistry  
 
Whole mount immunohistochemistry (IHC) was used to study axon development. Larvae stored 
in methanol were rehydrated by serial washing in PBS (Sigma Aldrich, St Louis, MO, USA).  Serial 
dilutions included 30, 50, and 70% PBS in methanol, before a final wash in 100% PBS) before two washes 
in PBST (PBS and 0,1% of Tween 20 [Sigma Aldrich]). The samples were then washed in acetone (Merk 
Millipore, Darmstadt, Germany) at -20⁰C for 20 minutes and transferred to 0,1% collagenase (Sigma 
Aldrich, C-5138) in PBST for 30 minutes to increase the permeability of the antibodies. After that, two 
more washes in PBST were done before transferring the larvae to a blocking solution, 10% normal goat 
serum in PBST, for two hours. This blocking solution is added to avoid nonspecific binding that may 
cause high background staining and that can mask the detection of the target antigen. Thereafter, larvae 
were incubated in the primary antibody anti-acetylated tubulin (α-AT. Mouse monoclonal anti-
acetylated tubulin, Sigma Aldrich, T-7451) at 1:4000, in blocking solution, over night at 4⁰C. The antigen 
of α-AT is the acetylated α-tubulin found in the axons. The following day, larvae were washed in PBST 
two times for 30 minutes to remove any unbound primary antibody and blocking solution. Then, the 
samples were incubated for 90 minutes in goat antimouse IgG secondary antiserum conjugated to Alexa 
Fluor 555 (Life Technologies, Carlsbad, CA, USA, A-21425) at 1:1000 dilution in PBST. This step will bind a 
fluorescence protein to the primary antibody. After incubation in secondary antibodies, larvae were 
washed three times in PBST for 30 minutes and preserved in slow fade solution (Life technologies, S-
36936) and stored at 4⁰C in darkness.  
 The samples ready for imaging were examined under the fluorescence microscope (Olympus 
1X81), at 100X magnification, using the TRITC red filter (Figure 7). Pictures of 10 axons in the trunk 
region were taken using the software included in the microscope (Cellsens Dimension Software). 
Thereafter, each axon length was measured using the imaging software ImageJ (Rasband 2014). 
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Figure 7. Pictures of α-AT staining in 48 hpf zebrafish. The picture is from a larvae injected with 5 µg/mL of 40 nm 
AuNPs. The white lines represent an example of the method used to measure axon length. 
 
Statistical Analyses 
 
All analyses were conducted in the R-environment (R_Development_Core_Team 2010). Dead 
larvae and deformed larvae were excluded from the behavioral and IHC analyses. 
To study the behavioral effects of AuNP size and dose on larvae, linear mixed effect models 
(LME) fitted by REML [function lme in nlme package of R, (Pinheiro et al. 2009)] were used. Initially, data 
of distance covered and time of activity of the larvae were analyzed in the three photoperiods (light-
dark-light) separately, but in the light photoperiods the movement was very low (few fish moved). 
Therefore, analyses of the light periods were excluded from this project. Subsequently, a two-way 
interaction model was built with the behavioral endpoints, time active or distance travelled per light 
phase, as the dependent variables, and AuNP size and dose as categorical independent variables (see R 
command 1 below). In addition, the model was run for each AuNP size separately (see R command 2 
below). Also, a three-way interaction model was used including AuNP size, dose and time of exposure as 
categorical independent variables, to analyze the consistency in behavioral endpoints between controls 
(see R command 3 below). In all the models described above, plate number was included as random 
effect.  
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1. Initial interaction model (example given for distance) 
lme(distance~size*dose, data=AuNPs, random= ~1|plate) 
2. Linear mixed effect model for AuNPs size separately (example given for AuNP20 nm) 
lme(distance~dose, data=AuNP20, random=~1|plate) 
3. Interaction model for controls (example given for activity) 
lme(activity~stage*size*dose, data=Controls, random= ~1|plate) 
The contrast values were used to determine significant differences between groups. For the 
embryo, behavioral results there appeared to be a dose response. To test this, we used the same 
models as described above, but we changed the dose from a categorical to a numerical variable. 
Measures of mortality at 100 hpf were studied using a generalized linear model [function glmer 
in lme4 package of R (R_Development_Core_Team 2010)]. The binary variables, live or dead (1,0) were 
studied in the model with “replicate” as random factor. Each AuNP size was analyzed separately.   
glmer(survival~dose+(1|replicate), family=”binomial”, data=AuNP20)  
For the immunohistochemistry assay, the length of each axon was studied using a general linear 
model [function glm in stats package of R (R_Development_Core_Team 2010)]. In the model, the 
variable “dose” was included as the fixed factor and each AuNP size was analyzed separately. 
glm(length~dose) 
For studying the effect of AuNPs on heart rate, a generalized linear model [function glm in stats 
package of R (R_Development_Core_Team, 2010)] was used. The model included the independent 
variable “dose” as the fixed factor and each AuNP size was analyzed separately.  
glm(data$heart~data$concentration) 
For each model mentioned above, an examination of the residual plots (q-q- plots) was 
conducted to verify that no systematic patterns occurred in the errors. Examples of the q-q plots from 
the behavior data can be found in the appendix. Model results of p-values <0,05 were considered 
significant. 
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Results 
 
Analyses of the locomotor behavior in the two controls showed consistent results across AuNPs 
sizes and time of exposure. No significant differences in distance covered or time of activity were found 
between the two controls used at each AuNP size test. In addition, controls show no significant 
differences between injected at 2 hpf and injected at 72 hpf (Table 5). 
 
Table 5. Modelled results from Linear Mixed Effect (LME) model analysis. The model included a three-way 
interaction between time of exposure, AuNP size and control type, namely distillated water (dH2O) and untreated. 
The results are for locomotor activity during the dark phase only. Embryo and larvae refer to exposures beginning 
at 2 hpf, and untreated embryos transferred to the analysis microtiter plates at 2 and 72 hpf, respectively.  
 Distance covered  Time active 
 Value DF t-value p-value  Value DF t-value p-value 
Embryo*AuNP20*dH2O (Intercept) 1161.89 598 13.07 0.000  152.58 598 14.313 0.000 
Larvae*AuNP20*dH2O -204.64 30 -1.61 0.118  -30.23 30 -1.981 0.057 
Embryo*AuNP40*dH2O 56.56 30 0.44 0.662  1.17 30 0.076 0.940 
Embryo*AuNP80*dH2O -9.95 30 -0.08 0.937  -2.76 30 -0.184 0.856 
Embryo*AuNP20*Untreated 24.11 598 0.30 0.767  9.58 598 0.957 0.339 
Larvae*AuNP40*H2O 224.28 30 1.24 0.224  32.73 30 1.510 0.142 
Larvae*AuNP80*H2O 164.57 30 0.92 0.365  25.85 30 1.206 0.237 
Larvae*AuNP20*Untreated 47.00 598 0.38 0.706  1.13 598 0.074 0.941 
Embryo*AuNP40*Untreated -43.36 598 -0.37 0.714  -2.87 598 -0.197 0.844 
Embryo*AuNP80*Untreated -26.25 598 -0.23 0.819  -2.51 598 -0.178 0.859 
Larvae*AuNP40*Untreated -253.12 598 -1.47 0.141  -25.96 598 -1.228 0.220 
Larvae*AuNP80*Untreated -194.46 598 -1.14 0.254  -18.61 598 -0.888 0.375 
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Behavioral differences during the dark phase were found related to AuNP size and 
concentration, in larvae exposed to AuNPs at 2-4 hpf. Irrespective of AuNP size, there was a reduction in 
the distance moved compared to the injection control in larvae (Figure 8). All AuNP size and 
concentrations showed a significant reduction in distance moved during the dark period (Table 6) with 
the exception of 50 µg/mL of 20 nm AuNP and 1mg/mL of 40nm AuNPs, but they still followed the 
general pattern of reduced distance moved compared to controls. In contrast, analysis of the time spent 
active, seconds moving in the 10 minutes dark period, showed significantly reduced values only in the 
high AuNP concentrations, including 500 and 1000 µg/mL of 20nm AuNPs, 500 µg/mL of 40 nm AuNPs 
and 100, 500 and 1000 µg/mL of 80 nm AuNPs. The tendency was also towards reduced activity in these 
cases. Only the 80 nm AuNP exposed larvae showed a clear concentration dependent reduction in 
locomotor responses (AuNP 80nm: Slope = -0.212, DF = 293, t = -3.102, p = 0.002; AuNP 40nm: Slope = -
0.044, DF = 301, t = -0.717, p = 0.473; AuNP 20nm: Slope = -0.108, DF = 311, t = -1.833, p = 0.068). 
Behavioral analyses of fish exposed as larvae, 72 hpf, did not show the same consistent patterns 
(Table 7 and Figure 9) as when exposed at embryo stage. Different AuNP sizes resulted in different 
patterns of behavior. AuNPs of 20 nm did not show any significant difference in distance covered or time 
of activity compared to controls. In the case of 80nm AuNPs, only a significant reduction in the time 
spent active was found for the 1000 µg/mL concentration, whereas concentrations of 1000 µg/mL and 5 
µg/mL showed significantly reduced distance covered. In contrast, reduced distance covered and time of 
activity was found at all concentrations, with the exception of 50 µg/mL, of 40 nm AuNPs. 
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Figure 8. Point graphs of locomotor activity during the dark period in zebrafish larvae exposed to three different 
sizes of AuNPs at 2 hpf. Data are means ± SE (n =  39-58/dose/AuNP size). Data is for the (A,C,E) distance moved 
and (B,D,F) time spent active during the 10 minute dark period. Different lower case letters indicate significant 
differences between doses (LME, p < 0,05).
 25 
  
Table 6. Modelled results from Linear Mixed Effect (LME) model analysis of both the distance covered and time spent active of larvae exposed to AuNPs at 
embryonic stage (2 hpf). P values in bold were considered significant (<0,05) 
 Distance covered – Embryo exposure 
 AuNPs 20 nm  AuNPs 40 nm  AuNPs 80 nm 
 Estimate DF T P  Estimate DF T P  Estimate DF T P 
Distillated water  1161,41 364 19,01 0,000  1217,22 348 12,11 0,000  1152,60 346 16,78 0,000 
Untreated 25,38 364 0,36 0,719  -17,26 348 -0,22 0,828  -0,71 346 -0,01 0,993 
5 µg/mL -146,84 364 -2,06 0,040  -163,00 348 -2,04 0,042  -156,36 346 -2,00 0,046 
50 µg/mL -133,25 364 -1,86 0,064  -185,87 348 -2,31 0,021  -180,49 346 -2,33 0,020 
100 µg/mL -144,59 364 -2,03 0,044  -179,67 348 -2,26 0,024  -272,07 346 -3,39 <0,001 
500 µg/mL -188,41 364 -2,59 0,010  -220,94 348 -2,78 0,006  -256,37 346 -3,12 0,002 
1000 µg/mL -191,41 364 -2,59 0,010  -146,26 348 -1,85 0,065  -328,15 346 -3,83 <0,001 
 Time active – Embryo exposure 
 AuNPs 20 nm  AuNPs 40 nm  AuNPs 80 nm 
 Estimate DF T P  Estimate DF T P  Estimate DF T P 
Distillated water  152,65 364 17,98 0,000  153,56 348 12,76 0,000  149,85 346 17,55 0,000 
Untreated 9,67 364 1,05 0,292  6,94 348 0,69 0,493  7,32 346 0,76 0,449 
5 µg/mL -12,09 364 -1,30 0,194  -12,37 348 -1,21 0,225  -11,73 346 -1,19 0,234 
50 µg/mL -15,72 364 -1,68 0,093  -16,42 348 -1,61 0,109  -16,86 346 -1,73 0,085 
100 µg/mL -13,85 364 -1,49 0,137  -15,24 348 -1,51 0,133  -29,74 346 -2,95 0,003 
500 µg/mL -23,97 364 -2,53 0,012  -22,98 348 -2,27 0,024  -29,68 346 -2,87 0,004 
1000 µg/mL -19,78 364 -2,05 0,040  -10,49 348 -1,04 0,297  -40,21 346 -3,73 <0,001 
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Figure 9. Point graphs of locomotor activity during the dark period in zebrafish larvae exposed to three different 
sizes of AuNPs at 72 hpf. Data are means ± SE (n =  51-60/dose/AuNP size). Data is for the (A,C,E) distance moved 
and (B,D,F) time spent active during the 10 minute dark period. Different lower case letters indicate significant 
differences between doses (LME, p < 0,05).
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Table 7. Modelled results from Linear Mixed Effect (LME) model analysis of both the distance covered and time spent active of larvae exposed to AuNPs at larval 
stage (72 hpf). P values in bold were considered significant (p<0,05) 
Distance covered – Larvae exposure 
 AuNPs 20 nm  AuNPs 40 nm  AuNPs 80 nm 
 Estimate DF T P  Estimate DF T P  Estimate DF T P 
Distillated water 985,43 369 11,54 0,000  1234,54 373 13,59 0,000  1123,32 373 9,18 0,000 
Untreated 128,54 369 1,47 0,144  -221,18 373 -2,59 0,010  -149,33 373 -1,74 0,082 
5 µg/mL -23,79 369 -0,30 0,765  -330,54 373 -3,71 <0,001  -186,58 373 -2,22 0,027 
50 µg/mL -53,15 369 -0,67 0,501  -111,41 373 -1,27 0,205  -136,03 373 -1,62 0,105 
100 µg/mL -11,79 369 -0,14 0,881  -185,56 373 -2,17 0,031  -75,88 373 -0,91 0,366 
500 µg/mL 39,46 369 0,49 0,622  -366,44 373 -4,23 <0,001  -140,81 373 -1,66 0,098 
1000 µg/mL 50,23 369 0,63 0,527  -369,82 373 -4,23 <0,001  -201,22 373 -2,38 0,018 
Time active – Larvae exposure 
 AuNPs 20 nm  AuNPs 40 nm  AuNPs 80 nm 
 Estimate DF T P  Estimate DF T P  Estimate DF T P 
Distillated water 124,47 369 13,23 0,000  156,04 373 14,67 0,000  147,18 373 9,04 0,000 
Untreated 15,07 369 1,44 0,151  -17,86 373 -1,76 0,080  -10,44 373 -0,94 0,346 
5 µg/mL -0,93 369 -0,10 0,923  -39,52 373 -3,73 <0,001  -19,18 373 -1,76 0,078 
50 µg/mL -2,30 369 -0,24 0,807  -17,69 373 -1,70 0,091  -15,60 373 -1,44 0,150 
100 µg/mL 1,42 369 0,15 0,880  -20,92 373 -2,06 0,040  -2,86 373 -0,26 0,792 
500 µg/mL 4,74 369 0,50 0,619  -41,91 373 -4,08 <0,001  -16,76 373 -1,53 0,127 
1000 µg/mL 10,42 369 1,01 0,272  -48,93 373 -4,71 <0,001  -25,88 373 -2,37 0,018 
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Survival was monitored throughout the behavioral assay. Mortality was very low when injected 
with any AuNP size at any concentration and never reached 50 % (Figure 10). However, mortality was 
significantly higher than controls when embryos were exposed to 80 nm AuNPs at 100, 500 and 1000 
µg/mL, and mortality was significantly lower than controls when larvae were exposed to 20 nm AuNPs at 
50 and 100 µg/mL. 
 
Figure 10. Point graph representing survival at 100 hpf of larvae injected with AuNPs at the A) Embrionic stage and 
B) larval stage. For controls, 0 represents embryos injected with distillated water and Ø represents untreated 
embryos. Data are means ± SE (n = 3/dose). Asterisks represent significant differences with distillated water 
controls (GLMER, * p <0,05 and ** p <0,01).  
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Axon length within embryos injected with AuNPs was measured at 48 hpf using IHC. In general, 
embryos exposed to AuNPs had shorter axons compared to controls, but this reduction in length was 
dependent on AuNP size and concentration (Figure 12). Embryos injected with 20nm AuNPs had shorter 
axons compared to controls when injected with 5 and 1000 µg/mL, whereas there was no significant 
difference to the controls after exposure to 100 µg/mL. In embryos injected with 40nm AuNPs, axons 
were shorter than the controls at all concentrations. For 80nm AuNPs, significantly shorter axons 
compared to controls were found when embryos were injected with concentrations of 100 and 1000 
µg/mL. In addition, within this AuNP size, embryos exposed to 1000 µg/mL had significantly shorter 
axons than embryos exposed to 100 µg/mL. 
 
Figure 11. Point graphs of axon length in 48 hpf zebrafish embryos exposed to AuNPs. Different lower case letters 
indicate significant differences between doses (GLM, p <0.05). Embryos were exposed to A) 20nm AuNPs, B) 40nm 
AuNPs, and C) 80nm AuNPs. Data are means ± SE (n = 9-12/dose). 
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Heart rate was measured in 48 hpf zebrafish exposed to AuNPs at 2 hpf. Irrespective of AuNP 
size, heart rate was lower in exposed larvae compared to controls (Figure 12). In addition, concentration 
dependent effects were found in 20nm AuNPs exposed larvae. Larvae exposed to 1 mg/mL 20nm AuNP 
had significantly lower heart rates than larvae exposed to 100 and 5 µg/mL. Otherwise, no dose effects 
were found within 40 and 80 nm AuNPs. 
 
Figure 12. Boxplots of the heart rate of larvae exposed to AuNPs at 2 hpf. Significant differences with the control 
were found in all AuNPs sizes and doses. The asterisk represent significant differences to controls (GLM, ** = p 
<0,001 and * = p <0,01). Different lowercase letters represent significant differences between doses within AuNP 
size (GLM, p <0.05). Boxes represent means and 50 % of the data. The whiskers represent the first and forth quartil 
of the data (n=20/dose). 
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Discussion 
 
Our objective was to test for behavioral effects and axon development in zebrafish exposed to 
AuNPs of different sizes. We found that zebrafish embryos exposed to AuNPs at 2 hpf showed a general 
reduction in motility compared to controls. In contrast, zebrafish exposed at 72 hpf with the same 
nanoparticles, resulted in some behavioral differences compared to controls, but there was no clear 
trend. Further, we found that the trend of reduced motility was dependent on nanoparticle size, 
irrespective of exposure time. In addition, we also found that AuNPs reduced axon length and heart rate 
in zebrafish larvae, two factors that are associated with locomotor activity. 
Prior to the study, we characterized our AuNPs through TEM and NTA analyses. We showed that 
nanoparticles were not aggregated and the particles were within the nanoscale. Previous studies show 
that exposing embryos by microinjection minimized the aggregation of nanoparticles compared to 
aqueous exposure (Wang et al. 2010).This is of great importance as particles in the nanosize possess 
different characteristics than the same particles of bigger size (Zhang et al. 2003, Buzea et al. 2007).  
Our analyses were conducted at sublethal doses of AuNPs though some mortality was found. In 
embryos exposed to AuNPs at 2 hpf, we found a trend of dose dependent decreased survival in 20 and 
80 nm AuNPs. Particularly, 80 nm AuNPs led to a dose dependent increase in mortality at high 
concentrations, indicating that this size is the most toxic. It has been shown before that AuNPs toxicity 
depends on several factors including nanoparticle size (Pan et al. 2007, Alkilany and Murphy 2010, Zhang 
et al. 2011). However, the optimal size for cell uptake in AuNPs is approximately 50 nm (Chithrani and 
Chan 2007), therefore we expected to find the highest toxicity in our study in exposures with AuNPs of 
40 nm. In larvae exposed at 72 hpf, we found no clear patterns in survival, but mortality was significantly 
lower than controls when exposed to 20 nm AuNPs at 50 and 100 µg/mL. In this test, there was high 
mortality in one replicate in the controls, both untreated and distillated water controls. Similar mortality 
was also found in controls of 80 nm AuNPs. The reason behind this unexpected high mortality, especially 
when healthy larvae were selected at 72 hpf, is unclear. One explanation could be the way the larvae 
were handled before the exposure. Here, larvae were kept in petri dishes at relatively high densities that 
were not standardized for every test, and this could compromise the viability of the larvae due to water 
quality. For future research, we propose to keep the individual embryos within the separate wells of 96 
well plate until the time of exposure. However, as the behavioral results are consistent between the 
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controls for the embryo and larvae exposures, we feel the behavioral results discussed below are 
reliable. 
To test if microinjection may have an effect on zebrafish behavior we used two controls, 
untreated and distillated water injections. Our results show that microinjection does not affect behavior 
compared to untreated embryos, with the exception of the controls used in the larvae exposed to 40nm 
AuNPs. The variation within the latter test may be explained by a trend for reduced movement of 
untreated larvae in one of the replicates. For example, the majority of controls moved on average 1157 
mm/10 min ± 375 (SD) whereas the untreated controls in one replicate for 40 nm AuNP test only moved 
703 mm/10 min ± 236 (SD). Although microinjection is a popular technique to introduce foreign material 
into zebrafish embryos, the effect of this technique on behavior has not been tested before. In a recent 
study, Liu an collaborators (2015) tested the damage of microinjections in zebrafish embryos. They 
concluded that a small needle radius and sharp needle tip, together with a large injection velocity, 
results in the least damage to the embryos. Thus, we used the smallest needle tip that could deliver the 
required volume at a high pressure in the current study. As such, we found microinjection has no 
discernable effect on zebrafish behavior, supporting the use of this method to study behavior effects on 
zebrafish larvae and that the locomotor behavior changes are exclusively explained by the effect of 
AuNPs.    
We evaluated the consistency of the controls with respect to the different behavioral endpoints 
and we found no effect of experiment replication. Distance covered and time active of controls were 
stable and without any significant differences across AuNP sizes and exposure stages tested. Consistency 
within the controls indicates that the zebrafish locomotor test are repeatable, and previous literature 
also found consistent results that support the repeatability and reliability of these tests (Selderslaghs et 
al. 2010, Padilla et al. 2011, de Esch et al. 2012, Ulhaq et al. 2013). 
 Previous research found that deformities could affect behavior, so we aimed to use exposure 
scenarios that did not result in high mortality or overt toxicity. We found that citrate coated AuNPs 
produce low mortality in the majority of our tests and few malformations in exposed embryos. 
Nevertheless, malformed embryos, with reduced head, severely curved spine or enlarged thorax, were 
still occasionally observed and excluded from the behavioral analyses, ensuring that the behavioral 
effects found were not due to these malformations. In a previous study, Padilla and collaborators (2011) 
showed that highly deformed larvae were hypoactive in the light phase and in the dark phase, but mildly 
abnormal larvae were hyperactive in the light phase but there was no effect in the dark phase. We did 
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not check for all the mild deformities listed in Padilla et al (2011), but in our analyses, we tested 
behavioral endpoints in the dark phase exclusively. Therefore, if these deformities were present, we do 
not expect them to influence our results. 
Our major finding was that embryos exposed to AuNPs at 2 hpf moved less during the dark 
phase compared to controls irrespective of particle size, but the same general effect was not apparent in 
the larvae exposed at 72 hpf. This suggest that AuNPs may have an effect on CNS development, because 
the brain is already developed by 48 hpf, rather than being a general neurotoxic effect. These findings 
support our first hypothesis that AuNPs disrupt normal CNS development that lead to alterations in 
behavior. Nevertheless, some effects were also found in larvae exposed at 72 hpf, particularly at low 
concentrations. Our results therefore match those of previous studies, whereby zebrafish exposed to 
AuNP from 6 hpf onwards showed a reduction in the distance moved during the dark phase, albeit the 
AuNPs used in their study differ in coating chemistry and size to ours (Truong et al. 2012, Kim et al. 
2013).  
 Uptake and distribution through the two exposure scenarios could explain the differences in 
behavioral results between larvae exposed at 2 and 72 hpf. For example, Wang et al (2010) injected 
AuNPs directly in zebrafish embryos, and found that the particles were efficiently taken up and 
distributed into different organs, including heart, brain and otic vesicle, during the development of the 
embryo (Wang et al. 2010), In contrast, AuNPs delivered into the bloodstream may not be so efficiently 
taken up. In a previous study, researchers found that citrate coated AuNPs bind with plasma proteins 
when the particles are exposed to blood. This binding results in an increased size that may affect the 
particles’ rate of uptake from the bloodstream (Dobrovolskaia et al. 2009). We did not test for this in the 
current study, but it would be of interest to determine AuNP fate in the current model following both 
exposure routes. 
Although clear general reductions in larvae swimming distance occurred when embryos were 
injected with AuNPs at 2 hpf, the intensity and dose effect varied between AuNP size. We show that 
whereas 80 nm AuNPs present a dose dependent swimming distance reduction, 20 and 40 nm AuNPs 
show a threshold response with a reduction in swimming distance at the lowest concentration, 5 µg/mL, 
but no stronger effects were found when the concentration increased. This suggests that AuNPs of 20 
and 40 nm may induce effects at concentrations under 5 µg/mL that we cannot analyze with our study 
design. In addition to dose dependent reduced swimming distance, 80 nm AuNPs also showed a dose 
dependent mortality. This correlation was only found at this AuNP size and may indicate that 80 nm 
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AuNPs are the most toxic, though the mechanisms are unclear. In a parallel study with the same AuNPs, 
Skadberg et al (unpublished data) found that 80 nm AuNPs stimulate higher proinflammatory response 
for tumor necrosis factor alpha (TNF-α) and Interleukin-1 beta (IL-1β) than 40 and 20 nm AuNPs. This 
immune response at high AuNP concentration, may affect both survival and behavior. Based on our 
results, we can reject our second hypothesis that, 40 nm AuNPs would be the most toxic, which was 
based on the efficiency in which particles are taken up by cells. 
Previous studies with AuNPs have used both higher and lower concentrations than our lowest 
dose of 5 µg/mL that we found to induce behavioral effects. However, it is difficult to compare dosing 
between studies as we used a one time injection whereas other studies have used continuous water 
exposure in which they did not measure uptake (Truong et al. 2012, Kim et al. 2013). We did microinject 
1 nL of AuNPs of concentrations of 5 to 1000 µg/mL, that represents an effective dose of 5*10-6 to 0,001 
µg/embryo. In previous studies, such as in Tourong et al (2012), they used aqueous exposure to AuNPs 
at concentrations of 10 to 50 µg/mL in a total of 100 µL of media. This is an effective concentration of 1 
to 5 µg/embryo of AuNP, considerably higher than that used in our study, but the amount taken up in 
these studies is unknown and therefore difficult to compare to our exposure dose. However, they found 
also a concentration dependent reduction in swimming distance in zebrafish larvae exposed to AuNPs. 
Yet, in that study, they tested different coated AuNPs rather than concentration. In the same line, Kim 
and collaborators (2013) show that zebrafish embryos exposed aqueous to 1,3 nm AuNPs coated with a 
cationic ligand found a tendency of reduced dose-dependent swimming distance of larvae exposed 
aqueous to concentrations from 0,1 to 10 mg/L.  
In larvae injected at 72 hpf, we found less clear effects than when injected in embryos at 2 hpf, 
but exposures to 40 and 80 nm AuNPs lead to hypoactive larvae at the lowest concentration, 5 µg/mL. 
Though the reasons behind this discrepancy is not clear, concentrations bellow 5 µg/mL may display a 
dose dependent effect. It has previously been reported that toxic effects may be stronger at low 
concentrations compared to higher concentrations of citrate coated AuNPs. For example, Fraga and 
collaborators (2013) show in a study with human liver cells (HepG2) that AuNPs produced genotoxic 
effects at low concentrations but not at high concentrations. The authors originally proposed that at 
high concentrations, AuNPs may aggregate more and therefore may not be able to reach the perinuclear 
region and induce direct DNA damage. However, the authors discarded this hypothesis because free 
AuNPs were not found in the cytosolic or perinuclear region of the tested cells, even at the lowest 
concentrations. Instead, Fraga et al (2011) found AuNPs accumulate and aggregate in vesicles 
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independently of the concentration. However, in our study, we found no behavioral effects in the 
intermediate concentrations, only in the highest and lowest concentrations. Furthermore, this effect 
varied depending on the AuNP size. For example, in larvae exposed to 20 nm AuNPs, we found no effect 
in distance moved, irrespective of dose. Therefore we conclude that AuNP size, dose, and exposure time 
and/or route are important with respect to behavioral effects, but the underlying mechanisms are yet to 
be determined. 
In addition to distance moved, we also measured the time spent active during the different light 
phases. Here, we found behavioral differences at high concentrations in larvae exposed at 2 hpf, but not 
at low concentrations of AuNPs. This means that at low concentrations, the reduction in distance moved 
during the dark phase was related to the speed of swimming. In larvae exposed at 72 hpf, only 40 nm 
AuNPs had clear reduction in activity time, in association with a reduction in distance travelled. The time 
spent active may be an indicator of environmental perception, and previously Kim et al (2013) describe 
in their study that cationic-coated AuNPs effect development of the eye in zebrafish larvae. This was 
also associated with a reduction in distance travelled during the dark phase (Kim et al 2013). However, 
the authors tested behavior at lower concentrations than those tested for eye malformations, so it is 
unclear whether the two are directly associated. Therefore, we feel our differences in effect on distance 
covered and time of activity indicates that the effects of AuNPs are more likely related to motor-
physiological responses rather than perception of the stimulus, but this remains to be tested. 
 We found a general reduction in axon length in embryos exposed to AuNPs at 2 hpf, as 
predicted in our first hypothesis. The outcome of axon underdevelopment due to AuNP exposure has 
been previously related to reduced swimming distances during the dark phase (Kim et al. 2013), as 
found in our study. Previous studies have also shown that effects on neuron and axon development 
caused by chemical exposure during embryonic development of zebrafish, are correlated with adverse 
effects on swimming behavior (Yang et al. 2011). In our study, we studied the axon length instead of 
axon aberrations as measured by Kim et al (2013). We found that the reduction in axon length varied 
depending on AuNP size. In 20 and 40 nm AuNPs, axons are shorter at the lowest concentration of 
AuNPs, but in 80 nm AuNPs a significant reduction of axon length appears at 100 µg/mL and the axons 
were even shorter at 1000 µg/mL. This dose-dependent axon length reduction of 80 nm AuNPs exposed 
larvae is consistent to the behavior and survival results. We propose that axon length, as axon 
aberration, is associated to behavioral effects. However, for definitive proof, axon length should be 
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measured directly after the locomotor test, which was not done in the current study due to the 
complexities of the assay. 
We found that embryos exposed to AuNPs at 2 hpf, showed a reduced heart rate at 48 hpf, in 
agreement with our third hypothesis. In a previous study, embryos injected with AuNPs have been 
found to accumulate AuNPs in the heart of zebrafish larvae at 48 hpf (Wang et al. 2010) but effects of 
AuNPs on the heart rate have not been reported. The reduction in heart rate may be related to lower 
metabolism and reduced activity. This has been previously shown in salmon, where heart rate was 
found to be positively associated to metabolic rate and swimming activity (Lucas 1994).  
For this study, we used zebrafish as an animal model. We have shown some of the possibilities 
in concern to behavioral analyses that can be conducted with zebrafish larvae. Robustness and reliability 
of the model have been presented in this study. The controls used, showed consistent results across the 
replicated sessions. In addition, ex utero development in zebrafish embryos represents a great 
advantage in toxicology studies, allowing us to study the development of the embryos directly. We can 
then choose a specific developmental stage to expose the embryos easily. In other animal models, this is 
more difficult and costly. Furthermore, by using microinjections, toxicity of substances can be studied 
locally at the different development stages or in a particular organ of the embryo. Microinjections in the 
brain, otic vesicle or eye are possible with this animal model. In addition, there is a great pool of well 
characterized genetically modified lines that can bring great advantages in pharmacology, medicine and 
toxicology. For instance, particularly useful in neurotoxicology is the transgenic zebrafish Isl1-GFP 
(Higashijima et al. 2000). This transgenic zebrafish express green fluorescence protein (GFP) in the 
cranial motor neurons, which would allow us to study the in vivo effect of nanoparticles or other 
substances on the neurological development of zebrafish. Other transgenic lines, such as ApoE-GFP 
zebrafish express GFP in microglial (Peri and Nüsslein-Volhard 2008). Microglia have phagocytic and 
immunological functions in the CNS. This line could be a great tool to study directly potential 
neurological immune responses to substances in zebrafish. 
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The use of AuNPs in biomedicine, brings important biosafety concerns. In this study, we 
demonstrated that AuNPs produce behavioral effects and axon under-development on zebrafish larvae. 
However, we used concentrations slightly above the dose used in medical treatments. In our study, we 
injected 1 nL of AuNPs solutions in concentrations between 5-1000 µg/mL. The volume-dose equivalent 
in humans would correspond to a dose range between 6-1210 mg of pure AuNPs. The dosage used in 
trials with Aurimune™, a tumor treatment drug that consist in AuNPs coated with anti-tumor drugs, was 
0,1-1,2 mg of the drug (Libutti et al. 2010). We found behavioral effects at our lowest concentrations, 
therefore it is plausible that behavioral effects may occur at lower concentrations still.  However, the 
neurotoxic effects that we have presented in this study are at the developmental stage, and effects on 
full-developed nervous system are not included in this study. 
 
Conclusions 
 
 In summary, we showed that citrate coated AuNPs have an effect on the swimming behavior of 
zebrafish. The intensity of the effect is dependent on the AuNP size and the time of exposure. 
Furthermore, we showed that citrate coated AuNPs effect axon growth, and this was also dependent on 
particle size and dose. In addition, we demonstrate that citrate coated AuNPs have an effect on heart 
rate in larvae. Though we have not tested the implications of this effect, lower heart rate may be related 
to reduced metabolic rate and furthermore, to behavioral activity. Finally, we have demonstrated some 
of the great possibilities that the zebrafish model has in nanoparticle toxicological studies. Further 
studies using this model should focus on looking at alternative neurological endpoints and other AuNPs 
types. 
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Further Research 
 
To further the current work, it would be of interest to study in more detail how exposure time 
and particle characteristics effect behavior. For instance, we could microinjected AuNPs at 24 hpf 
directly in the brain ventricle (Gutzman and Sive 2009), that would be of interest for study how AuNPs 
affect the brain. Furthermore, we could include different coating AuNPs such as polyethylene glycol 
(PEG), as this functionalization prevents nonspecific protein absorption and aggregation of particles. 
Also this coating is widely used in biomedical treatments (Brown et al. 2010, Patra et al. 2010). In 
addition, as we found behavioral effects at all our doses, we would repeat the current endpoints with 
lower concentrations than the used here, under 5 µg/mL. 
We found AuNP effects on axon length using IHC, but the zebrafish model may also be used to 
study this endpoint in vivo. For example, the transgenic line Isl1-GFP that has fluorescence 
motoneurons. By using this embryos of this transgenic line, the effects in motor neuron development 
can be studied in vivo (Higashijima et al. 2000). 
In the current study we measured behavior at 96 hpf, but the zebrafish in vitro model also 
allows for study of some other behaviors that may provide further information on potential toxic 
pathways. Additionally, different behavioral endpoints could be analyzed. The automated tracking 
system allows us to conduct different tests, including photo-motor response (PMR) and the 
sensorimotor response test. The PMR is based on a stereotypical motor behavior exhibited by larvae at 
early stages, 30 to 42 hpf, after being exposed to an intense light stimulus. Several studies proposed that 
toxicants with similar mechanisms of neurotoxicity display a similar behavior response to this stimulus 
(Kokel et al. 2010, Rihel et al. 2010). The sensorimotor response test measures the startle response of 
zebrafish larvae to vibrational stimuli. The startle response of zebrafish larvae to an acoustic stimulus is 
robust and consistent, therefore the inhibition or reduction can be studied. The inhibition or attenuation 
of this response has been associated to neurological disorders (Burgess and Granato 2007). 
The present study is relatively descriptive in nature. This is a valuable starting point to 
determine whether new substances are a health concern, but having found such evidence, further work 
should attempt to elicit the toxic mechanisms. To do this, future work should focus on AuNPs uptake 
and biological fate, and molecular pathways.  We propose to analyze our AuNPs exposed larvae under 
the ORION microscope. This microscopy technology is based on helium ion beams, and with this 
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technology, we could study directly the distribution of the AuNPs in the zebrafish larvae body, for 
instance, if AuNPs accumulate in the CNS or in muscle tissue. Furthermore, it would be of interest to 
study different approaches to connect physiological effects to behavioral endpoints in order to better 
understand the mechanisms behind behavioral phenotypes. Future studies on the genes that regulate 
motor neuron development could link behavioral effects to physiological and molecular effects. 
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Appendix  
 
A1. Q-Q plots of the residuals from the Linear mixed effect (LME) models.  
 
Figure A.1.1. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP20, random=~1|plate) and 
lme(activity~dose, data=AuNP20, random=~1|plate). Data for embryos exposed to 20 nm AuNPs at 2 hpf. 
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Figure A.1.2. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP40, random=~1|plate) and 
lme(activity~dose, data=AuNP40, random=~1|plate). Data for embryos exposed to 40 nm AuNPs at 2 hpf. 
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Figure A.1.3. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP80, random=~1|plate) and 
lme(activity~dose, data=AuNP80, random=~1|plate). Data for embryos exposed to 80 nm AuNPs at 2 hpf. 
 
 
 
 
Distance vs Dose 
Activity vs Dose 
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Figure A.1.4. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP20, random=~1|plate) and 
lme(activity~dose, data=AuNP20, random=~1|plate). Data for embryos exposed to 20 nm AuNPs at 72 hpf. 
 
 
 
 
Distance vs Dose 
Activity vs Dose 
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Figure A.1.5. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP40, random=~1|plate) and 
lme(activity~dose, data=AuNP40, random=~1|plate). Data for embryos exposed to 40 nm AuNPs at 72 hpf. 
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Figure A.1.6. Q-Q plots of residuals from the LME model lme(distance~dose, data=AuNP80, random=~1|plate) and 
lme(activity~dose, data=AuNP80, random=~1|plate). Data for embryos exposed to 80 nm AuNPs at 72 hpf. 
 
 
 
Distance vs Dose 
Activity vs Dose 
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Figure A.1.7. Q-Q plots of residuals from the LME model lme(distance~dose*size, data=AuNPs, random=~1|plate) 
and lme(activity~dose*size, data=AuNPs, random=~1|plate). Data for embryos exposed at 2 hpf to all AuNP sizes. 
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Figure A.1.8. Q-Q plots of residuals from the LME model lme(distance~dose*size, data=AuNPs, random=~1|plate) 
and lme(activity~dose*size, data=AuNPs, random=~1|plate). Data for embryos exposed at 72 hpf to all AuNP sizes. 
 
 
 
Distance vs Dose*Size 
Activity vs Dose*Size 
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Figure A.1.9. Q-Q plots of residuals from the LME model lme(distance~dose*stage*size, data=Controls, 
random=~1|plate) and lme(activity~dose*size, data=AuNPs, random=~1|plate). Data for control embryos injected 
with distillated water and untreated. 
 
 
A2. Immunohistochemistry pictures. 
 
 
 
 
 
 
 
 
 
Figure A.2.1. Picture of α-AT staining in 48 hpf zebrafish larvae. The picture is from a control larvae 
injected with distillated water.  
 
Control 
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Figure A.2.2. Pictures of α-AT staining in 48 hpf zebrafish larvae. The pictures are from larvae injected 
with 20 nm AuNPs. A scale and the dose are marked on each picture. 
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Figure A.2.3. Pictures of α-AT staining in 48 hpf zebrafish larvae. The pictures are from larvae injected 
with 40 nm AuNPs. A scale and the dose are marked on each picture. 
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Figure A.2.4. Pictures of α-AT staining in 48 hpf zebrafish larvae. The pictures are from larvae injected 
with 80 nm AuNPs. A scale and the dose are marked on each picture. 
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A3. Raw data from the behavioral tests. 
 
Due to the large amount of data, these have been uploaded to the following Google Drive 
folder:  
https://drive.google.com/folderview?id=0B9Uysx5a38Kcfk1CVnVleUpYbFpZVGxCcHJsQUZZcVhiWEFaaE
VJNXNNOG9wNjB1N3Nmc1U&usp=sharing 
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